Genome Sequencing
基因组测序
基本信息
- 批准号:10245046
- 负责人:
- 金额:$ 21.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-15 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAnimal ModelAreaBioinformaticsBiological SciencesBiologyBiomedical EngineeringBiomedical ResearchBusinessesCell physiologyCenters of Research ExcellenceChromatinCommunicationCore FacilityCustomDNA Sequencing FacilityDNA sequencingDataDevelopmentDisciplineDiseaseDisease PathwayDissectionEcologyElementsExperimental DesignsFluorescenceFluorescent ProbesFoodGenerationsGenesGeneticGenomeGenomicsGenotypeGoalsInfrastructureInstitutionIowaKansasLibrariesLocationMethodsMicroarray AnalysisMolecularMolecular AnalysisMuseumsMutationNatural HistoryNetwork InfrastructurePartner in relationshipPathway interactionsPharmacy SchoolsPreparationProtocols documentationResearchResearch PersonnelRunningSequence AnalysisSignal PathwaySiteSmall RNASynthesis ChemistryTechniquesTechnologyTrainingUniversitiesVariantWashingtonWichitaWorkchromatin immunoprecipitationcostexperimental analysisgenome sequencinghigher educationinstrumentinterestnext generation sequencingnovelnovel strategiesoutreachtooltranscription factortranscriptometranscriptome sequencingwhole genome
项目摘要
PROJECT SUMMARY
Next generation sequencing is now a central tool in the analysis of signaling pathways important in
development and disease. The Genome Sequencing Core (GSC) is aimed at providing researchers at the
University of Kansas and the state of Kansas with next-generation sequencing technologies as well as
expertise in experimental design and analysis of sequence data. Projects in the GSC include whole genome
assembly, genome re-sequencing for identification of mutations important in development and disease,
transcriptome analysis (RNA seq), variant mapping and genotyping, and identification of transcription factor
interaction sites using chromatin immunoprecipitation combined with DNA sequencing (ChIP seq). The GSC
houses an Illumina Hiseq 2500 sequencer and a MiSeq sequencer with dedicated processor and storage
space to run the instrument.
This core facility has enhanced the genomics infrastructure already at KU, in the KU Genomics Center and
the KU DNA Sequencing Facility, which provides standard, first generation sequencing. Together, the three
cores allow for a thorough, integrated dissection of disease pathways using novel fluorescence probes to
define a cellular process, to find mutations affecting that cellular process, and to define genes involved in the
cellular process. The novel approach of the CMADP is to combine the enabling technologies of fluorescent
probe synthetic chemistry and next generation sequencing to set up a pipeline for target discovery in disease
pathways.
Next generation sequencing is an enabling technology in that it has the power to allow investigators from
many different disciplines to ask new questions in their research areas of interest. The GSC enables genomics
research at the University of Kansas by eliminating the barriers of cost and communication involved with using
off-campus facilities. Interest in next generation sequencing at the University of Kansas is high, and includes
investigators in the Pharmacy School, the Department of Molecular Biosciences, and the Department of
Ecology and Evolutionary Biology. Use of the GSC will be by Projects in the COBRE Center for Molecular
Analysis of Disease Pathways, as well as by researchers across the State of Kansas and in many different
disciplines.
项目摘要
下一代测序现在是分析信号通路的核心工具,
发展和疾病。基因组测序核心(GSC)旨在为研究人员提供
堪萨斯大学和堪萨斯州的下一代测序技术,以及
实验设计和序列数据分析方面的专业知识。GSC的项目包括全基因组
组装,基因组重新测序,用于鉴定在发育和疾病中重要的突变,
转录组分析(RNA seq)、变体作图和基因分型以及转录因子的鉴定
使用染色质免疫沉淀结合DNA测序(ChIP seq)检测相互作用位点。则GSC
包含Illumina Hiseq 2500测序仪和MiSeq测序仪,配有专用处理器和存储器
空间来运行仪器。
这一核心设施增强了KU基因组学中心的基因组学基础设施,
KU DNA测序设施,提供标准的第一代测序。在一起,三个
核心允许使用新的荧光探针对疾病途径进行彻底的、综合的解剖,
定义一个细胞过程,找到影响细胞过程的突变,并定义参与细胞过程的基因。
细胞过程CMADP的新方法是联合收割机结合荧光
探针合成化学和下一代测序,为疾病中的靶点发现建立管道
途径。
下一代测序是一种使能技术,因为它有能力让研究人员从
许多不同的学科在他们感兴趣的研究领域提出新的问题。GSC使基因组学
研究在堪萨斯大学通过消除成本和沟通的障碍,涉及使用
校外设施堪萨斯大学对下一代测序的兴趣很高,包括
研究人员在药学院,分子生物科学系,和系
生态学与进化生物学GSC将由COBRE分子中心的项目使用
疾病途径的分析,以及堪萨斯州和许多不同地区的研究人员
学科
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Erik A Lundquist其他文献
Erik A Lundquist的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Erik A Lundquist', 18)}}的其他基金
Regulation of directed neuroblast migration by the ECM and MAB-5/Hox
ECM 和 MAB-5/Hox 对定向神经母细胞迁移的调节
- 批准号:
10469982 - 财政年份:2020
- 资助金额:
$ 21.02万 - 项目类别:
Regulation of directed neuroblast migration by the ECM and MAB-5/Hox
ECM 和 MAB-5/Hox 对定向神经母细胞迁移的调节
- 批准号:
10689337 - 财政年份:2020
- 资助金额:
$ 21.02万 - 项目类别:
Regulation of directed neuroblast migration by the ECM and MAB-5/Hox
ECM 和 MAB-5/Hox 对定向神经母细胞迁移的调节
- 批准号:
10250549 - 财政年份:2020
- 资助金额:
$ 21.02万 - 项目类别:
Using RNA-seq to identify Hox transcriptional targets in neuronal migration
使用 RNA-seq 识别神经元迁移中的 Hox 转录靶标
- 批准号:
8015905 - 财政年份:2010
- 资助金额:
$ 21.02万 - 项目类别:
Using RNA-seq to identify Hox transcriptional targets in neuronal migration
使用 RNA-seq 识别神经元迁移中的 Hox 转录靶标
- 批准号:
8103813 - 财政年份:2010
- 资助金额:
$ 21.02万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




